FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of medicine, namely to pharmaceutical industry and deals with solid pharmaceutical composition, possessing high physical strength. Claimed invention also presents method of manufacturing solid pharmaceutical composition. Claimed pharmaceutical composition contains 7 varicoloured types of granules in form of capsule. Granules contain, wt %: nikotinamide 1-35; pyridoxine 0.1-8; calcium pantitenate 0.1-15, thiamin 0.1-30; tryptophan 1-30; tocoferol 0.5-5; ascorbic acid 0.1-50; 5-hydroxyanthranyl acid 0.01-10; Riboflavin 0.1-10; folic acid 0.1-6; cyanocobalomin 0.001-6; isoleucin 0.5-10; leucin 0.5-15; lysine 0.5-20; phenylalanine 0.1-5; threonine 0.1-5.0; valin 0.1-8.0; methionine 0.1-15; lactose 1-4.0; ergocalcioferol 1-95.0 and auxiliary substances for obtaining granules.
EFFECT: claimed composition possesses excellent properties of medication release and digectionin application composition possesses hepatoprotective hypolipidemic immunostimulating and normalising kidney activity action.
2 cl. 2 ex. 5 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
PHARMACEUTICAL COMPOSITION IN THE FORM OF A COATED TABLET | 2022 |
|
RU2786073C1 |
METHOD FOR PRODUCTION OF ANTIOXIDANT PREPARATION IN FORM OF TABLET | 2020 |
|
RU2749718C1 |
COMBINED MEDICINAL PREPARATION IN FORM OF EFFERVESCENT TABLETS AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2686694C2 |
METHOD OF PRODUCING AN ANTIOXIDANT AGENT IN THE FORM OF A TABLET WITH PROLONGED EFFECT | 2019 |
|
RU2712445C1 |
PHARMACEUTICAL COMPOSITION WITH ANTIPSYCHOTIC ACTION | 2009 |
|
RU2420304C2 |
PHARMACEUTICAL COMPLEX FORMULATION COMPRISING ANGIOTENSIN II RECEPTOR BLOCKER AND HMG-CoA REDUCTASE INHIBITOR | 2014 |
|
RU2662565C2 |
COMPOSITIONS OF ANTIBIOTIC | 2004 |
|
RU2376980C2 |
GRANULATES CONTAINING ESLICARBAZEPINE ACETATE | 2011 |
|
RU2625747C2 |
Authors
Dates
2013-06-10—Published
2011-07-25—Filed